Similar phenotype was observed in the B16TDO model (Supplementary Fig. 2e) and other cancer cell line models expressing high levels of IDO in baseline conditions, such as the breast carcinoma 4T12 and colorectal cancer model MC3820. Here, IDO1 is linked to cancer.